Form 4: IGM Biosciences Principal Accounting Officer Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Steven Weber, Principal Accounting Officer of IGM Biosciences, sold 469 shares of common stock on September 13, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On September 13, 2024, Steven Weber, the Principal Accounting Officer of IGM Biosciences, sold 469 shares of the company's common stock.
  • The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
  • The shares were sold at a weighted average price of $11.5388, with individual transactions ranging from $11.20 to $11.795.
  • Following the transaction, Weber directly owns 25,543 shares of IGM Biosciences common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document reports a routine stock sale for tax purposes, with no indication of significant positive or negative implications for the company.

Industry Context

This is a routine Form 4 filing related to an insider stock sale to cover tax obligations, a common occurrence in publicly traded companies.

Stakeholder Impact

  • The sale of shares by a company officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

DateDescription
09/13/2024Date of the stock sale transaction.
09/17/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.